ImmunologybioRxivPreprint
Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor responsein prostate cancer
C. de Aguiar Ferreira, H. K. Potluri, C. Massey…·R. Hernandez
This study shows that 225Ac-NM600, an alpha-emitting radiopharmaceutical, enhances anti-tumor responses in prostate cancer by modulating the immune microenvironment.
DOI 10.1101/2022.09.26.509374